Antihistamines as an early treatment for Covid-19

Infection with SARs-COV-2 results in COVID-19 disease. Between March 2020 and August 2021, 468 COVID-19 patients confirmed by PCR or antigen test, in Yepes, Spain, received early treatment with antihistamines, adding azithromycin in selected cases. The primary endpoint is the hospitalization rate of...

Descripción completa

Detalles Bibliográficos
Autores principales: Morán Blanco, Juan Ignacio, Alvarenga Bonilla, Judith A., Fremont-Smith, Philip, Villar Gómez de las Heras, Karina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129342/
https://www.ncbi.nlm.nih.gov/pubmed/37128299
http://dx.doi.org/10.1016/j.heliyon.2023.e15772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129342/
https://www.ncbi.nlm.nih.gov/pubmed/37128299
http://dx.doi.org/10.1016/j.heliyon.2023.e15772

Ejemplares similares